A TP73-AS1/miR-200a/ZEB1 regulating loop promotes breast cancer cell invasion and migration
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A TP73-AS1/miR-200a/ZEB1 regulating loop promotes breast cancer cell invasion and migration
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 119, Issue 2, Pages 2189-2199
Publisher
Wiley
Online
2017-08-31
DOI
10.1002/jcb.26380
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation
- (2017) Shaling Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- ZEB1-regulated inflammatory phenotype in breast cancer cells
- (2017) Akihiro Katsura et al. Molecular Oncology
- The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer
- (2017) Karen Hanrahan et al. Molecular Oncology
- The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
- (2017) Angela M. Krebs et al. NATURE CELL BIOLOGY
- Role of EMT in Metastasis and Therapy Resistance
- (2016) Bethany Smith et al. Journal of Clinical Medicine
- ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma
- (2015) Katsumi Terashita et al. JOURNAL OF CLINICAL PATHOLOGY
- Wide expression of ZEB1 in sarcomatous component of spindle cell carcinoma of the esophagus
- (2015) Takuro Nakazawa et al. PATHOLOGY INTERNATIONAL
- Tissue invasion and metastasis: Molecular, biological and clinical perspectives
- (2015) W.G. Jiang et al. SEMINARS IN CANCER BIOLOGY
- TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis
- (2015) Sudhakar V. Nuti et al. Oncotarget
- MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell
- (2014) Yuhua Lu et al. BMC CANCER
- Downregulated microRNA-200a promotes EMT and tumor growth through the Wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma
- (2013) NINGNING CONG et al. ONCOLOGY REPORTS
- Expression of snail, twist, and Zeb1 in malignant mesothelioma
- (2012) Heta Merikallio et al. APMIS
- EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness
- (2012) Ester Sánchez-Tilló et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Overexpression of ZEB1 associated with metastasis and invasion in patients with gastric carcinoma
- (2012) Baoqing Jia et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma
- (2011) Aidong Shen et al. JOURNAL OF SURGICAL ONCOLOGY
- Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells
- (2010) Yoshihiro Takeyama et al. CANCER LETTERS
- Molecular interactions in cancer cell metastasis
- (2009) Susan A. Brooks et al. ACTA HISTOCHEMICA
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Downregulated MicroRNA-200a in Meningiomas Promotes Tumor Growth by Reducing E-Cadherin and Activating the Wnt/ -Catenin Signaling Pathway
- (2009) O. Saydam et al. MOLECULAR AND CELLULAR BIOLOGY
- Zeb1 links epithelial-mesenchymal transition and cellular senescence
- (2008) Y. Liu et al. DEVELOPMENT
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
- (2008) Jing Yang et al. DEVELOPMENTAL CELL
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now